Search - tctmd.com

Displaying 861 - 880 of 4184

Sort: Relevancy | Date

Presentation ECHO/IMAGING 2019

Prosthetic Valve Thrombus vs. Pannus

Presenter: Sorin Pislaru

March 23, 2019

Presentation ECHO/IMAGING 2019

Case: 80 yo female with prior AVR

Presenter: Jeremy Thaden

March 23, 2019

Presentation ECHO/IMAGING 2019

Low-Gradient Severe(?) AS

Presenter: Philippe Pibarot

March 22, 2019

Presentation ECHO/IMAGING 2019

Can We Standardize the Definition of Structural Prosthetic Valve Dysfunction?

Presenter: Rebecca T. Hahn

March 22, 2019

Presentation ECHO/IMAGING 2019

Basic Assessment of Prosthetic Valve Function - ASE Prosthetic Valve Guidelines

Presenter: Jeremy Thaden

March 22, 2019

Presentation ECHO/IMAGING 2019

Aortic Stenosis - Basic and Advanced Measurements

Presenter: Jae K. Oh

March 22, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

Presentation ACC 2019

Primary Results From the Evolut Low Risk Trial

Presenter: Michael J. Reardon

March 17, 2019

Presentation ACC 2019

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Presenter: Martin B. Leon

March 17, 2019

News Daily News

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

L.A. McKeown

March 13, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Industry News

Innovative Cardiovascular Solutions Announces First Use of its Next-Generation Emblok™ Embolic Protection System in European Feasibility Study

March 05, 2019

News Daily News

Signal of Aortic Stenosis Risk With Celecoxib

Michael O'Riordan

March 05, 2019

Presentation CRT 2019

Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis

Presenter: Ron Waksman

March 05, 2019

Presentation CRT 2019

The BASILICA Trial: Prospective multi-center investigation of intentional leaflet laceration to prevent TAVR coronary obstruction

Presenter: Jaffar M. Khan

March 05, 2019

News Conference News CRT 2019

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

Yael L. Maxwell

March 04, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

Advertisement

Prosthetic Valve Thrombus vs. Pannus

Case: 80 yo female with prior AVR

Low-Gradient Severe(?) AS

Can We Standardize the Definition of Structural Prosthetic Valve Dysfunction?

Basic Assessment of Prosthetic Valve Function - ASE Prosthetic Valve Guidelines

Aortic Stenosis - Basic and Advanced Measurements

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Primary Results From the Evolut Low Risk Trial

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Innovative Cardiovascular Solutions Announces First Use of its Next-Generation Emblok™ Embolic Protection System in European Feasibility Study

Signal of Aortic Stenosis Risk With Celecoxib

Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis

The BASILICA Trial: Prospective multi-center investigation of intentional leaflet laceration to prevent TAVR coronary obstruction

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content